by Blood
Acknowledging the limitations of murine and primary cell models in predicting clinical outcomes with chimeric antigen receptor (CAR) T cell therapy, researchers created an immunocompetent nonhuman...
by Blood
Innate lymphoid cells (ILCs) derived from hematopoietic stem cells mitigate graft-versus-host disease (GVHD) in human and mice models but, until now, how they do so has not been fully understood.
by Journal of Transplantation and Cellular Therapy
Checking for tumor-associated circulating cell-free DNA (TA-cfDNA) after allogeneic stem cell transplantation for acute myelogenous leukemia (AML) could serve as a predictive marker for relapse...
by Nature
Researchers compared outcomes with different conditioning regimens before allogeneic hematopoietic cell transplantation (allo-HCT) in patients ≥ 50 years with myelodysplastic...
by ASTCT Talks
In this episode of ASTCT’s Titans of Transplant series, Dr. Taha Al-Juhaishi welcomes Dr. Sattva Neelapu of MD Anderson Cancer Center for a deep and insightful conversation on the evolution,...
by Alex Kadhim
Researchers at the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation have found that haploidentical transplantation with posttransplant cyclophosphamide...